Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

SQREEM's New AI-powered Study Examines Motivations Surrounding COVID-19 Vaccine Resistance in the US

Misinformation fuels skepticism and confusion; varying impact on the attitudes of vaccine-resistant people despite shared struggles with isolation and concerns of economic ramifications


News provided by

SQREEM Technologies

Dec 15, 2021, 09:00 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Dec. 15, 2021 /PRNewswire/ -- COVID-19 vaccines have once again become a hot topic in the United States as President Joe Biden pushes on with vaccination mandates in a bid to manage concerns around the Omicron variant ahead of the winter flu season. Despite vaccination rates reaching  60%, vaccination coverage remains uneven across the fifty states, with many Americans identifying with and embracing labels such as 'anti-vaxxer' as a form of social identity. 

Continue Reading
The Anti-Vaxxer and The Vaccine Hesitant
The Anti-Vaxxer and The Vaccine Hesitant
View PDF

Leveraging proprietary Artificial Intelligence (AI) built to understand online human behavior in a completely anonymous way, SQREEM Technologies' recent U.S. COVID-19 Vaccine Study provides a striking insight into the attitudes and motivations of anti-vaxxers and the vaccine-hesitant. The study utilizes anonymized digital engagement scores as the main metric to understand audience relevance to topics/aspects surrounding COVID-19 vaccination. In the study, 'anti-vaxxers' are audiences that do not agree with the COVID-19 vaccine and its use, while 'vaccine-hesitant' are audiences that are reluctant to use the COVID-19 vaccine despite its availability. For both groups, digital engagement scores with values greater than 5 signify awareness, while values greater than 10 signify a strong engagement with the topic.

Overall, the study found that anti-vaxxers are confused about the topic of COVID-19 vaccination, considering vaccines to be an inconvenience and ineffective. On the other hand, vaccine-hesitant persons are significantly more confused and tend to have misconceptions about vaccines; however, they showed stronger engagement towards topics and content directly related to various vaccine brands.

"At SQREEM, we believe in the power of tech for good, to uplift lives and bring social and economic progress for all. We recognize that many challenges still exist in the fight against this global pandemic, including people's hesitancy towards vaccination. The goal of this study was to develop a better understanding of the attitudes and rationales behind vaccine resistance to help healthcare professionals, regulators and policymakers find innovative ways to tackle the challenges," said Ian Chapman-Banks, CEO and co-founder of SQREEM.  

Safety, level of protection worries anti-vaxxers

Taking a closer look, the study found that anti-vaxxers are highly concerned about vaccine ingredients (10.45) and often search for information regarding COVID-19 vaccines and live viruses. Unwilling to get vaccinated because they fear that vaccines may contain live viruses (6.05), they however show an interest in knowing about the efficacy rate of various vaccines (5.8). Safety of vaccines administered (8.06) and concerns about the duration of protection offered (7.96) are top reasons that shape the attitudes of anti-vaxxers who predominantly worry about blood clots as a possible adverse side effect of COVID-19 vaccinations (5.77). Anti-vaxxers also showed a high interest in anti-vaccine protests (8.68) and were found to be heavily influenced by opinions of vaccine skeptics (11.86), including public and political personalities.

Anxiety outweighs health protection interests for the vaccine-hesitant

In comparison, vaccine-hesitant people turned to pro-vaccine key opinion leaders (10.14) such as medical professionals for information significantly more than they referenced vaccine skeptics (5.6). Interestingly, they also demonstrated a strong interest in vaccine myths and conspiracies (9.74). Curious about the ingredients (23.99) and mechanism of action (12.66) for various vaccine brands, this group also showed a strong interest in searching about vaccine appointments online (12.25). But despite being highly interested in the long-term personal health protection offered by COVID-19 vaccines (26.3), their vaccine-resistant behavior is driven by skepticism around the efficacy of vaccines and concerns over possible side effects, with blood clots (13.53) and death (9.23) being their primary fears.

Resistance heightens as the pandemic prolongs   

The study also noted important changes in the online behavior of both groups as the COVID-19 pandemic progressed. While both groups showed a greater affinity towards religious leaders, the vaccine-hesitant increasingly placed value on the opinion of celebrities. Notably, mainstream media such as TV and radio become the main sources of information for both groups. 

While concerned about the higher severity of infections (9.55), anti-vaxxers' rejection of vaccines was driven by longer-term concerns, including the inefficiency of vaccines against new variants and severe infections (5.32), and increased interest in side-effect myths, particularly the belief that vaccines alter a person's DNA (6.25). This group also felt strongly that people with underlying conditions should not get vaccinated (17) and showed high engagement on topics surrounding vaccines and fertility.

Despite their fears about the greater risk of transmission (9.9), the vaccine-hesitant remain skeptical about the technology used to develop vaccines (5.38) and believe it is unsafe for children (6.43) and breastfeeding women (5.09) to be vaccinated. Their pre-existing belief in myths compounded their fears of vaccine side effects, including concerns about increased susceptibility to COVID-19 (9.3), links to Bell's Palsy (7.13) and cancer caused by altered DNA (8.11), harmful effects from shedding of vaccine components (7.39) and human magnetism (6.81).   

Ian added, "Insights from this study indicate that an important aspect of overcoming vaccine resistance lies in understanding the behavior of people and applying this knowledge to address their concerns. Tailoring messages to be meaningful and to resonate with different audiences can be effective in countering misinformation and conspiracy theories. Promote open, honest conversations by leveraging people's existing trust in their own doctors and health care providers to direct vaccine-resistant people to professionals for reliable information."

Methodology

The U.S. COVID-19 Vaccine Study employs SQREEM Technologies' proprietary AI technology to analyze anonymized monthly online behaviors including searches, interactions on websites, apps, and publicly available social interactions, on topics surrounding COVID-19 vaccination in the United States.

'Anti-vaxxers' are audiences that do not agree with the COVID-19 vaccine and its use, while 'vaccine-hesitant' are audiences that are reluctant to use the COVID-19 vaccine despite its availability.

Monthly behaviors are represented by online engagement scores. Values between 0 and 5 signify unawareness, 5 to 10 signify awareness, while values greater than 10 signify a strong engagement with the topic. Engagement scores are deemed relevant and can be used to understand the level of engagement by the audience with the topic. 

About SQREEM

SQREEM is the world's largest "behavioural pattern data aggregator" that collects, analyses, and creates a database of open data on the Internet using its own AI technology. Based on this technology, we provide data analysis and programmatic targeting services to more than 100 companies and government agencies across various industries. SQREEM has also been identified as one of Asia's fastest-growing companies by the Financial Times for two years running.

In 2021, the company introduced ONE Market, the world's first AI-enabled media exchange. ONE Market merges all of SQREEM's tech stack layers, delivering an optimised end-to-end solution that seamlessly connects the right audience with the right digital destination, when and where behaviours take place. ONE Market is purposefully designed as a plug and play platform to work directly into an agency's current workflow.

See the following link for more details.
https://SQREEMtech.com

SOURCE SQREEM Technologies

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.